Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

New agency

- PMLiVE

GSK pays $50m upfront to tap Immatics’ cell therapy platform

Deal focuses on T cell receptor therapies

- PMLiVE

Immutep spikes on trial of its LAG-3 drug with Keytruda

Impressive mid-stage results in NSCLC and HNSCC

- PMLiVE

Ex-BMS exec jumps to Gilead to lead research group

Gilead appoints Michael Quigley to lead research team

Digital divergence

Combining digital and pharma is proving less easy than previously thought

- PMLiVE

Incyte launches award programme recognising innovation in GVHD community

Programme aims to support people with graft-versus-host disease

- PMLiVE

AbbVie/Allergan merger faces renewed public opposition despite divestments

Consumer groups and public interest organisations raise new concerns

- PMLiVE

Merck KGaA divests allergy business to Dermapharm

The sum of the agreement remains undisclosed

- PMLiVE

Teva’s weak pipeline hit by Tourette’s drug trial failure

Drug wasn't able to improve on placebo

- PMLiVE

Incyte’s JAK inhibitor cream clears second eczema trial

Set for regulatory filings later this year

- PMLiVE

Lucid Group shine the spotlight on mental and physical health

Lucid kick-started its health and wellbeing agenda for the year with a focus on physical and mental wellbeing by taking inspiration from an elite sportsman, James Rodwell. James, a decorated...

Lucid Group Communications Limited

- PMLiVE

Novo Nordisk awakens its ‘Sleeping Beauty’

Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott

- PMLiVE

Porterhouse announces members of medical advisory group

Group provides first-hand clinical experience to colleagues and clients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links